UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.47B |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$2.93B |
| 3 |
Vanguard Russell 1000 Value ETF
VONV
|
+$2.75B |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.69B |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$2.33B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.44B |
| 2 |
Micron Technology
MU
|
+$919M |
| 3 |
CYBR
CyberArk
CYBR
|
+$851M |
| 4 |
Honeywell
HON
|
+$606M |
| 5 |
Merck
MRK
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.16% |
| 2 | Technology | 16.96% |
| 3 | Financials | 8.4% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5351
Benitec Biopharma
BNTC
$313M
| $1.23M | ﹤0.01% |
115,819
+17,472
| +18% | +$202K |
2020 Q2
23 quarters
|
|
5352
FT Energy Income Partners Strategy ETF
EIPX
$554M
| $1.23M | ﹤0.01% |
38,353
+479
| +1% | +$14.3K |
2024 Q1
8 quarters
|
|
5353
Tronox
TROX
$628M
| $1.23M | ﹤0.01% |
125,872
-251,137
| -67% | -$1.74M |
2014 Q4
45 quarters
|
|
|
OSG
5354
Octave Specialty Group
OSG
$207M
| $1.23M | ﹤0.01% |
264,280
+110,416
| +72% | +$632K |
2014 Q4
45 quarters
|
|
5355
MGP Ingredients
MGPI
$274M
| $1.23M | ﹤0.01% |
66,779
-2,290
| -3% | -$51.1K |
2015 Q1
44 quarters
|
|
|
KFII
5356
K&F Growth Acquisition Corp II
KFII
$419M
| $1.23M | ﹤0.01% |
117,719
+98,749
| +521% | +$1.03M |
2025 Q2
3 quarters
|
|
|
SRTA
5357
Strata Critical Medical Inc
SRTA
$418M
| $1.23M | ﹤0.01% |
293,593
+151,186
| +106% | +$728K |
2020 Q3
22 quarters
|
|
5358
CALL
CarMax
KMX
$7.8B
| $1.23M | ﹤0.01% |
29,500
-142,500
| -83% | -$6.24M |
2025 Q2
3 quarters
|
|
5359
CALL
Group 1 Automotive
GPI
$2.98B
| $1.22M | ﹤0.01% |
+3,700
| New | +$1.29M |
2026 Q1
0 quarters
|
|
|
5360
PUT
Group 1 Automotive
GPI
$2.98B
| $1.22M | ﹤0.01% |
+3,700
| New | +$1.29M |
2026 Q1
0 quarters
|
|
|
XRN
5361
Chiron Real Estate Inc
XRN
$450M
| $1.22M | ﹤0.01% |
36,883
+11,334
| +44% | +$398K |
2016 Q4
37 quarters
|
|
5362
First Trust Limited Duration Investment Grade Corporate ETF
FSIG
$1.51B
| $1.22M | ﹤0.01% |
+64,412
| New | +$1.23M |
2026 Q1
0 quarters
|
|
|
QMMM
5363
DELISTED
QMMM Holdings
QMMM
| $1.22M | ﹤0.01% |
10,208
| – | – |
2024 Q4
5 quarters
|
|
|
BIOA
5364
BioAge Labs
BIOA
$303M
| $1.22M | ﹤0.01% |
69,482
+39,603
| +133% | +$763K |
2024 Q4
5 quarters
|
|
5365
OPAL Fuels
OPAL
$52.7M
| $1.21M | ﹤0.01% |
481,947
-49,022
| -9% | -$113K |
2022 Q3
14 quarters
|
|
5366
CALL
Blue Owl Capital
OWL
$6.21B
| $1.21M | ﹤0.01% |
133,000
+36,800
| +38% | +$445K |
2025 Q4
1 quarter
|
|
5367
ProFrac Holding
ACDC
$834M
| $1.21M | ﹤0.01% |
195,796
-271,418
| -58% | -$1.45M |
2023 Q2
11 quarters
|
|
|
LOVE
5368
LoveSac
LOVE
$212M
| $1.21M | ﹤0.01% |
82,147
-147,496
| -64% | -$1.95M |
2018 Q2
31 quarters
|
|
|
FISV
5369
CALL
Fiserv Inc
FISV
$23.6B
| $1.21M | ﹤0.01% |
21,700
+1,900
| +10% | +$118K |
2020 Q4
21 quarters
|
|
5370
Castle Biosciences
CSTL
$1.09B
| $1.21M | ﹤0.01% |
49,163
-92,710
| -65% | -$3.04M |
2019 Q3
26 quarters
|
|
|
ENHA
5371
Enhanced Group Inc
ENHA
$201M
| $1.21M | ﹤0.01% |
118,611
+48,389
| +69% | +$490K |
2025 Q4
1 quarter
|
|
|
ELVA
5372
Electrovaya
ELVA
$328M
| $1.21M | ﹤0.01% |
154,144
+123,238
| +399% | +$1.07M |
2025 Q3
2 quarters
|
|
5373
CALL
Blue Owl Capital
OBDC
$5.08B
| $1.2M | ﹤0.01% |
+108,800
| New | +$1.28M |
2026 Q1
0 quarters
|
|
5374
Black Diamond Therapeutics
BDTX
$109M
| $1.2M | ﹤0.01% |
564,838
+307,205
| +119% | +$731K |
2023 Q2
11 quarters
|
|
5375
Standard Motor Products
SMP
$838M
| $1.2M | ﹤0.01% |
34,577
+22,465
| +185% | +$887K |
2014 Q4
45 quarters
|
|
Similar funds
UBS Group's Q1 2026 Portfolio in Review
As of Q1 2026, UBS Group held 11,786 positions worth $666B, up 8% from $617B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $74.2B of net new capital in Q1 2026, opening 1,344 new positions and adding to 4,798 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 38% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was UBS Group, an estimated $1.44B trimmed.
- UBS Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
- UBS Group added most to iShares Core MSCI EAFE ETF in Q1 2026, an estimated $4.47B increase.
- UBS Group's biggest Q1 2026 reduction was UBS Group, cutting an estimated $1.44B.
- UBS Group fully exited CyberArk in Q1 2026, selling an estimated $851M.
- UBS Group's ten largest holdings make up 13% of its $666B portfolio in Q1 2026.
- UBS Group opened 1,344 new positions and closed 1,383 in Q1 2026.
- UBS Group's portfolio value rose 8% quarter-over-quarter to $666B.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.